Tracked shipping to New Zealand with premium packaging for just NZ$15 

Ship to
New Zealand
0
  • argentina
  • chile
  • colombia
  • españa
  • méxico
  • perú
  • estados unidos
  • internacional

Select your country

Americas

Europe

Rest of the world

portada Evaluation of Inflammatory Bowel Disease, an Issue of Gastroenterology Clinics: Volume 41-2
Type
Physical Book
Publisher
Year
2012
Language
English
Pages
1
Format
Hardcover
Dimensions
23.1 x 15.2 x 2.0 cm
Weight
0.57 kg.
ISBN
1455746274
ISBN13
9781455746279

Evaluation of Inflammatory Bowel Disease, an Issue of Gastroenterology Clinics: Volume 41-2

Adam Harris (Author) · Samir Shah (Author) · Edward Feller (Author) · Saunders · Hardcover

Evaluation of Inflammatory Bowel Disease, an Issue of Gastroenterology Clinics: Volume 41-2 - Shah, Samir ; Feller, Edward ; Harris, Adam

New Book Imported to New Zealand
Delivery: 13 Jul - 20 Jul Shipping: 11 to 12 business days.
NZ$ 163.20
Used BookGood Condition Imported to New Zealand
Delivery: 09 Jul - 21 Jul Shipping: 9 to 13 business days.
NZ$ 50.89
Import costs and 15% GST included in the price ✅
NZ$ 163.20

Synopsis "Evaluation of Inflammatory Bowel Disease, an Issue of Gastroenterology Clinics: Volume 41-2"

The Guest Editors have focused on methods of diagnosing and evaluating IBD to help guide optimal treatment to maximize clinical outcomes and minimize risks. Authors have provided state-of-the-art updates with practical information/guidelines/algorithms and cutting-edge data for incorporation into practice. The first set of articles deals with endoscopy: its role in diagnosis and monitoring IBD; the growing importance of chromoendoscopy in IBD surveillance exams; assessment of post-operative recurrence; and finally the emerging role of capsule endoscopy. The second section focuses on specific scenarios that IBD physicians encounter frequently: health maintenance in IBD focusing on proper vaccinations; the growing problem of Clostridium difficile in IBD; assessment of pouch problems; optimal evaluation of perianal disease; the state of the art in using thiopurines including use of allopurinol to optimize metabolites and optimizing the use of infliximab by measuring levels and antibodies to infliximab; factors to consider in choosing monotherapy versus combination therapy and communication of risk/benefit to patients; and finally disability assessment in IBD. The third and final section highlights noninvasive methods to evaluate IBD: clinical predictors of aggressive or disabling disease; the evolving role of specific antibodies in diagnosing, subtyping and most recently prognosticating in IBD; stool markers (calproctectin and lactoferrin) for evaluating and monitoring IBD; the growing role of imaging modalities with emphasis on MR enterography and CT enterography; and finally, the genetics of IBD and the potential role of genetic testing in the diagnosis/prognosis and tailoring of therapy.

Customers reviews

Frequently Asked Questions about the Book

All books in our catalog are Original.
The book is written in English.
The binding of this edition is Hardcover.

Questions and Answers about the Book

Do you have a question about the book? Login to be able to add your own question.

Opinions about Bookdelivery

More customer reviews